Sunrise Stock

We make a 3-gram sensor to diagnose sleep with gold standard quality.

Sign up today and learn more about Sunrise Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Sunrise Stock

Sunrise aims to bring simple answers to millions of people suffering from sleep disorders. We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate as in-lab sleep studies, at a fraction of the cost. Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases. Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.

Funding History

December 2019$1.0M
June 2021$1.9M
December 2021$6.5M
March 2023$17.0M


Co-Founder & CEO

Laurent Martinot

Co-Founder & CTO

Pierre Martinot

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: